Herbal constituent sequoyitol improves hyperglycemia and glucose intolerance by targeting hepatocytes, adipocytes, and β-cells.
暂无分享,去创建一个
Mengle Shao | K. Cho | Yong Liu | Liang Sheng | Hong Shen | Zheng Chen | Suqing Wang | Ting Wang | Liangyou Rui
[1] L. Rui,et al. Lipocalin-13 Regulates Glucose Metabolism by both Insulin-Dependent and Insulin-Independent Mechanisms , 2010, Molecular and Cellular Biology.
[2] D. Brautigan,et al. D-Chiro-Inositol Glycans in Insulin Signaling and Insulin Resistance , 2010, Molecular medicine.
[3] H. Ashida,et al. D-Pinitol and myo-Inositol Stimulate Translocation of Glucose Transporter 4 in Skeletal Muscle of C57BL/6 Mice , 2010, Bioscience, biotechnology, and biochemistry.
[4] C. Ostenson,et al. Antidiabetic Effect of Gynostemma pentaphyllum Tea in Randomly Assigned Type 2 Diabetic Patients* , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[5] R. A. Caceres,et al. Molecular dynamics studies of a hexameric purine nucleoside phosphorylase , 2010, Journal of molecular modeling.
[6] S. Subramanian,et al. Attenuation of oxidative stress and alteration of hepatic tissue ultrastructure by D-pinitol in streptozotocin-induced diabetic rats , 2010, Free radical research.
[7] G. Hotamisligil,et al. Mechanisms of TNF-alpha-induced insulin resistance. , 2009 .
[8] Xiu-wei Yang,et al. [Effects of chemical constituents of Crossostephium chinense on insulin secretion in rat islets in vitro]. , 2009, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[9] L. Rui,et al. Identification of MUP1 as a Regulator for Glucose and Lipid Metabolism in Mice* , 2009, Journal of Biological Chemistry.
[10] T. Rademacher,et al. Reciprocal Control of Pyruvate Dehydrogenase Kinase and Phosphatase by Inositol Phosphoglycans , 2008, Journal of Biological Chemistry.
[11] J. Baillargeon,et al. Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. , 2008, Metabolism: clinical and experimental.
[12] W. Cefalu,et al. Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans. , 2008, Endocrine, metabolic & immune disorders drug targets.
[13] Xiu-wei Yang,et al. [Studies on chemical constituents from whole plants of Crossostephium chinense]. , 2008, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[14] Robert H. Michell,et al. Inositol derivatives: evolution and functions , 2008, Nature Reviews Molecular Cell Biology.
[15] G. Meer,et al. Membrane lipids: where they are and how they behave , 2008, Nature Reviews Molecular Cell Biology.
[16] Minghua Li,et al. Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. , 2007, The Journal of clinical investigation.
[17] Min‐Jung Kang,et al. Pinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitus. , 2006, Journal of medicinal food.
[18] M. Hassanein,et al. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. , 2006, The British journal of general practice : the journal of the Royal College of General Practitioners.
[19] J. Bushweller,et al. Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin action. , 2005, Biochemistry.
[20] Minghua Li,et al. Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. , 2005, Cell metabolism.
[21] R. Przybylski,et al. Urinary chiro-Inositol and myo-inositol Excretion is Elevated in the Diabetic db/db Mouse and Streptozotocin Diabetic Rat , 2003, Experimental biology and medicine.
[22] Han-Dong Sun,et al. Chemical constituents from Amentotaxus yunnanensis and Torreyayunnanensis. , 2003, Journal of natural products.
[23] A. M. Nasser,et al. Tetrahydroisoquinoline alkaloids and 2-deoxyribonolactones from Aristolochia arcuata. , 2003, Phytochemistry.
[24] Bei B. Zhang,et al. Glucagon and regulation of glucose metabolism. , 2003, American journal of physiology. Endocrinology and metabolism.
[25] M. White,et al. IRS proteins and the common path to diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.
[26] B. Wilson,et al. G(q/11) is involved in insulin-stimulated inositol phosphoglycan putative mediator generation in rat liver membranes: co-localization of G(q/11) with the insulin receptor in membrane vesicles. , 2002, Biochemical and biophysical research communications.
[27] M. White,et al. Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.
[28] C. Kahn,et al. Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.
[29] G. Shulman,et al. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. , 2001, The Journal of clinical investigation.
[30] C. Bailey,et al. Insulin‐like effect of pinitol , 2000, British journal of pharmacology.
[31] Roger Davis,et al. The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.
[32] M. Prentki,et al. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. , 2000, Diabetes.
[33] T. Rademacher,et al. Inositol phosphoglycans in diabetes and obesity: urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes. , 1999, Molecular genetics and metabolism.
[34] K. Uysal,et al. Functional Analysis of Tumor Necrosis Factor (TNF) Receptors in TNF-α-Mediated Insulin Resistance in Genetic Obesity* * This work is supported in part by a grant from the NIH (DK-52539). , 1998, Endocrinology.
[35] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.
[36] G. Panayotou,et al. Phosphoinositide 3-kinases: a conserved family of signal transducers. , 1997, Trends in biochemical sciences.
[37] B. Spiegelman,et al. Tumor Necrosis Factor (TNF)-α Inhibits Insulin Signaling through Stimulation of the p55 TNF Receptor and Activation of Sphingomyelinase* , 1996, The Journal of Biological Chemistry.
[38] P. De Camilli,et al. Phosphoinositides as Regulators in Membrane Traffic , 1996, Science.
[39] B. Spiegelman,et al. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] I. Asplin,et al. chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[41] C. Villar-Palasi,et al. Insulin mediator stimulation of pyruvate dehydrogenase phosphatases. , 1992, Archives of biochemistry and biophysics.
[42] K. Kikuchi,et al. Purification and characterization of Mg2+-dependent glycogen synthase phosphatase (phosphoprotein phosphatase IA) from rat liver. , 1981, European journal of biochemistry.
[43] U. Boggi,et al. The beta-cell in human type 2 diabetes. , 2010, Advances in experimental medicine and biology.
[44] J. Li,et al. Saponins isolated from the root of Panax notoginseng showed significant anti-diabetic effects in KK-Ay mice. , 2008, The American journal of Chinese medicine.
[45] D. Jakubowicz,et al. Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome. , 2000, Journal of pediatric endocrinology & metabolism : JPEM.